Sensitivity, but Not Specificity, of a Quantitative Immunochemical Fecal Occult Blood Test for Neoplasia Is Slightly Increased by the Use of Low-Dose Aspirin, NSAIDS, and Anticoagulants-Reference-Cited by-同舟云学术

Sensitivity, but Not Specificity, of a Quantitative Immunochemical Fecal Occult Blood Test for Neoplasia Is Slightly Increased by the Use of Low-Dose Aspirin, NSAIDS, and Anticoagulants

Published:2009-03-17 Issue:4 Volume:104 Page:933-938
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:
Short-container-title:Am J Gastroenterol

Author:

Levi Zohar,Rozen Paul,Hazazi Rachel,Vilkin Alex,Waked Amal,Maoz Eran,Birkenfeld Shlomo,Lieberman Nicky,Klang Shmuel,Niv Yaron

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference14 articles.

1. A quantitative immunochemical faecal occult blood test is more efficient for detecting significant colorectal neoplasia than a sensitive guaiac test

2. 1,300 mg of Aspirin Daily Does Not Cause Positive Fecal Hemoccult Tests

3. Do aspirin and nonsteroidal anti-inflammatory drugs cause false-positive fecal occult blood test results? A prospective study in a cohort of veterans

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of antithrombotic treatment on the fecal immunochemical test for colorectal cancer screening: a nationwide cross-sectional study;Endoscopy;2023-01-26

2. Screening for Colorectal Cancer;Hematology/Oncology Clinics of North America;2022-06

3. Impact of antithrombotic drugs on the accuracy of fecal occult blood testing for advanced colorectal neoplasia screening: a meta-analysis and systematic review;Zeitschrift für Gastroenterologie;2022-05-17

4. Impact of antiplatelet agents and anticoagulants on the performance of fecal immunochemical tests: a systematic review and meta-analysis;Surgical Endoscopy;2021-10-29

5. Comparative effectiveness of five fecal immunochemical tests using colonoscopy as the gold standard: study protocol;Contemporary Clinical Trials;2021-07